Magazine article Drug Topics

Lupin's Global Integrated Team Focuses on Delivering High-Quality Generics

Magazine article Drug Topics

Lupin's Global Integrated Team Focuses on Delivering High-Quality Generics

Article excerpt

Lupin Pharmaceuticals, Inc. (LPI), a wholly owned subsidiary of Lupin Ltd., is among the top 4 pharmaceutical companies in India. With its sales and marketing headquarters located in Baltimore, Md., LPI is dedicated to delivering affordable, high-quality generic medications.

Recognized as one of the top 10 fastest-growing generic manufacturers for the third year in succession, LPI 's prescribing rate has grown more than 51%. LPI 's generics business is ranked 5th in total generic prescriptions dispensed, according to IMS Health's National Prescription Audit (March 2011).

"The U.S. generic business is one of Lupin's primary drivers of value creation," said Bob Hoffman, Senior Vice President, Sales and Marketing, Generics Division. "Lupin continues to increase its market share for most of its marketed products through increased focus on execution, strong relationships with trade partners, and an efficient and responsive supply chain, all supported by a globally integrated team determined to explore better ways to create value."

Of the 30 generic products marketed in the United States, 14 are market leaders in terms of market share. Lupin holds the top 3 positions in 27 of these 30 generic products, and its growth is driven equally by inline as well as new product introductions. "A very lucrative product pipeline, new product launches, deep customer relationships, and world-class intellectual property capabilities have been the key to the success of our U.S. generics business," said Hoffman. "As the fastest growing generic player in the United States, we believe that we have the required momentum in place to accelerate this growth further. The ceiling is far from reached as we are yet to realize the true value of one of the best generic pipelines in the U.S. market."

A Robust Pipeline

Lupin continues to invest in building up its robust pipeline of important new products. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.